Carcinoma in Situ of the Urinary Bladder
📧 Sign up to get email alerts when something new happens for Carcinoma in Situ of the Urinary Bladder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2016-04-07FDA Approved: VALSTAR — Supplemental Application (Endo USA, Inc.)
FDA approved a supplemental application for VALSTAR (valrubicin) from Endo USA, Inc., resulting in updated labeling for the product.
-
FDA approval · 2014-01-17FDA Approved: VALSTAR — Supplemental Application (Endo USA, Inc.)
FDA approved a supplemental application for VALSTAR (valrubicin) from Endo USA, Inc., potentially expanding or updating its labeling for use…
-
FDA approval · 2013-08-02FDA Approved: VALSTAR — Supplemental Application (Endo USA, Inc.)
FDA approved a supplemental application for VALSTAR (valrubicin) submitted by Endo USA, Inc., updating labeling via a supplemental approval.